EXACT Therapeutics AS (OSL:EXTX)
2.200
+0.370 (20.22%)
At close: Mar 13, 2026
EXACT Therapeutics AS Market Cap
EXACT Therapeutics AS has a market cap or net worth of 139.18 million as of March 13, 2026. Its market cap has decreased by -34.52% in one year.
Market Cap
139.18M
Enterprise Value
81.03M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.20
Market Cap Chart
Since July 14, 2020, EXACT Therapeutics AS's market cap has decreased from 953.69M to 139.18M, a decrease of -85.41%. That is a compound annual growth rate of -28.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 139.18M | 59.42% |
| Dec 30, 2025 | 87.30M | -63.30% |
| Dec 30, 2024 | 237.87M | -38.21% |
| Dec 29, 2023 | 384.97M | 6.95% |
| Dec 30, 2022 | 359.97M | -31.02% |
| Dec 30, 2021 | 521.86M | -40.97% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 14, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Thor Medical ASA | 1.69B |
| Circio Holding ASA | 1.14B |
| ArcticZymes Technologies ASA | 1.10B |
| Nykode Therapeutics AS | 969.84M |
| Lytix Biopharma AS | 811.30M |
| Zelluna ASA | 457.09M |
| SoftOx Solutions AS | 183.63M |
| Arctic Bioscience AS | 91.65M |